-+ 0.00%
-+ 0.00%
-+ 0.00%

VERRICA PHARMACEUTICALS: CO ADVANCING VP-315 TOWARD PHASE 3 PROGRAM FOR BASAL CELL CARCINOMA IN 2026

Reuters·03/11/2026 12:00:05

Please log in to view news